Oppenheimer Asset Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Buy |
22,599
+2,992
| +15% | +$267K | 0.02% | 558 |
|
|
2025
Q4 | $1.55M | Sell |
19,607
-1,702
| -8% | -$133K | 0.02% | 569 |
|
|
2025
Q3 | $1.7M | Sell |
21,309
-2,338
| -10% | -$199K | 0.02% | 611 |
|
|
2025
Q2 | $2.15M | Sell |
23,647
-207
| -0.9% | -$18.9K | 0.02% | 532 |
|
|
2025
Q1 | $2.24M | Buy |
23,854
+9,815
| +70% | +$879K | 0.03% | 487 |
|
|
2024
Q4 | $1.28M | Buy |
14,039
+59
| +0.4% | +$5.63K | 0.02% | 657 |
|
|
2024
Q3 | $1.45M | Sell |
13,980
-13,880
| -50% | -$1.41M | 0.02% | 638 |
|
|
2024
Q2 | $2.7M | Buy |
27,860
+678
| +2% | +$62.5K | 0.03% | 451 |
|
|
2024
Q1 | $2.45M | Sell |
27,182
-7,006
| -20% | -$594K | 0.04% | 431 |
|
|
2023
Q4 | $2.73M | Sell |
34,188
-536
| -2% | -$40.3K | 0.04% | 424 |
|
|
2023
Q3 | $2.47M | Sell |
34,724
-1,429
| -4% | -$107K | 0.04% | 423 |
|
|
2023
Q2 | $2.79M | Sell |
36,153
-1,073
| -3% | -$83.1K | 0.04% | 418 |
|
|
2023
Q1 | $2.8M | Buy |
37,226
+11,260
| +43% | +$837K | 0.04% | 406 |
|
|
2022
Q4 | $2.05M | Buy |
25,966
+3,362
| +15% | +$252K | 0.03% | 474 |
|
|
2022
Q3 | $1.59M | Buy |
22,604
+187
| +0.8% | +$14.7K | 0.03% | 516 |
|
|
2022
Q2 | $1.8M | Sell |
22,417
-309
| -1% | -$24.2K | 0.03% | 498 |
|
|
2022
Q1 | $1.72M | Sell |
22,726
-375
| -2% | -$29.7K | 0.02% | 583 |
|
|
2021
Q4 | $1.97M | Buy |
23,101
+161
| +0.7% | +$12.6K | 0.03% | 556 |
|
|
2021
Q3 | $1.73M | Sell |
22,940
-1,319
| -5% | -$105K | 0.02% | 581 |
|
|
2021
Q2 | $1.97M | Buy |
24,259
+1,320
| +6% | +$108K | 0.03% | 544 |
|
|
2021
Q1 | $1.81M | Buy |
22,939
+2,088
| +10% | +$164K | 0.03% | 539 |
|
|
2020
Q4 | $1.78M | Sell |
20,851
-97
| -0.5% | -$8.02K | 0.03% | 510 |
|
|
2020
Q3 | $1.62M | Sell |
20,948
-1,381
| -6% | -$105K | 0.03% | 486 |
|
|
2020
Q2 | $1.64M | Sell |
22,329
-34
| -0.2% | -$2.42K | 0.03% | 450 |
|
|
2020
Q1 | $1.48M | Buy |
22,363
+17,147
| +329% | +$1.21M | 0.04% | 418 |
|
|
2019
Q4 | $359K | Buy |
5,216
+311
| +6% | +$21.2K | 0.01% | 913 |
|
|
2019
Q3 | $360K | Sell |
4,905
-130
| -3% | -$9.43K | 0.01% | 885 |
|
|
2019
Q2 | $361K | Sell |
5,035
-218
| -4% | -$15.5K | 0.01% | 906 |
|
|
2019
Q1 | $360K | Sell |
5,253
-21
| -0.4% | -$1.36K | 0.01% | 883 |
|
|
2018
Q4 | $314K | Sell |
5,274
-2,368
| -31% | -$148K | 0.01% | 883 |
|
|
2018
Q3 | $511K | Sell |
7,642
-342
| -4% | -$22.8K | 0.01% | 802 |
|
|
2018
Q2 | $518K | Sell |
7,984
-823
| -9% | -$53.8K | 0.01% | 787 |
|
|
2018
Q1 | $631K | Sell |
8,807
-50,901
| -85% | -$3.66M | 0.02% | 725 |
|
|
2017
Q4 | $4.35M | Hold |
59,708
| – | – | 0.12% | 206 |
|
|
2017
Q3 | $4.35M | Buy |
59,708
+560
| +0.9% | +$40.4K | 0.11% | 208 |
|
|
2017
Q2 | $4.38M | Buy |
59,148
+909
| +2% | +$67.5K | 0.12% | 196 |
|
|
2017
Q1 | $4.26M | Buy |
+58,239
| New | +$4.08M | 0.12% | 197 |
|
Other funds holding CL
VCM
DAM
VPM
Oppenheimer Asset Management's CL Position: Q1 2026 in Review
Oppenheimer Asset Management increased its Colgate-Palmolive (CL) stake by 15% in Q1 2026, buying an estimated $267K and bringing the position to 22,599 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #558.
Oppenheimer Asset Management first reported a position in CL in Q1 2017 and has held it in 37 quarters since. The position peaked at $4.38M in Q2 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Oppenheimer Asset Management held 22,599 shares of Colgate-Palmolive worth $1.93M as of Q1 2026.
- Oppenheimer Asset Management bought 2,992 Colgate-Palmolive shares in Q1 2026, an estimated $267K.
- Colgate-Palmolive made up 0.02% of Oppenheimer Asset Management's portfolio in Q1 2026, its #558 holding.
- Oppenheimer Asset Management first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 37 quarters since.
- Oppenheimer Asset Management's Colgate-Palmolive position peaked at $4.38M in Q2 2017.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.